claim: the d614g mutation of sars-cov-2 spike protein enhances viral infectivity and enhanced neutralization sensitivity to individual convalescent sera
evidence_1: the spike protein that mediates sars- cov-2 entry into host cells, is one of the major targets for vaccines and therapeutics.